A drug approved to treat lung cancer substantially shrank tumors in mice that were caused by a rare form of bone cancer called chordoma reveals John Hopkins researchers.
Reporting in the journal iPLOS ONE/i, the researchers say the finding offers hope to chordoma patients, who have no treatment options once surgery and radiation have been exhausted. There are no U.S. Food and Drug Administration-approved medications for the disease and, because its incidence is only one in 1 million, there ...
A drug approved to treat lung cancer substantially shrank tumors in mice that were caused by a rare form of bone cancer called chordoma reveals John Hopkins researchers.
Reporting in the journal iPLOS ONE/i, the researchers say the finding offers hope to chordoma patients, who have no treatment options once surgery and radiation have been exhausted. There are no U.S. Food and Drug Administration-approved medications for the disease and, because its incidence is only one in 1 million, there ...